Previous Article | Next Article ![]()
Infection and Immunity, May 2001, p. 3413-3417, Vol. 69, No. 5
Department of Infectious and Tropical
Diseases, London School of Hygiene and Tropical Medicine, London,
United Kingdom,1 and Dhoolpet Leprosy
Research Centre, Hyderabad, India2
Received 1 September 2000/Returned for modification 30 December
2000/Accepted 22 February 2001
The effects of prednisolone treatment on the cellularity and
cytokine (gamma interferon, interleukin-12, and inducible nitric oxide
synthase) profiles of leprosy skin type 1 (reversal) reactions were
studied using immunohistochemistry. Skin biopsies were taken from 15 patients with leprosy type 1 (reversal) reactions at days 0, 7, 28, and
180 after the start of steroid treatment. Prednisolone treatment had
little effect at day 7, but by day 28 significant decreases were found
in cytokine levels. Some patients maintained cytokine production at
days 28 and 180. These results illustrate the strong Th1 profile of
type 1 reactional lesions, the slow response to steroid therapy, and
continuing activity at 180 days.
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.5.3413-3417.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Immunohistochemical Analysis of Cellular Infiltrate and Gamma
Interferon, Interleukin-12, and Inducible Nitric Oxide Synthase
Expression in Leprosy Type 1 (Reversal) Reactions before and during
Prednisolone Treatment
*
Corresponding author. Mailing address: Department of
Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St., London, WCIE 7HT, United Kingdom. Phone: 020 7927 2457. Fax: 020 7637 4314. E-mail:
Diana.Lockwood{at}lshtm.ac.uk.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»